Archive Newsletter
-
10.13.26 -- Structuring CGT Deals For The Long Term With Troutman Pepper Locke's EA Weeks, J.D., Ph.D.
10/13/2026
10/13/26 Cell & Gene Newsletter
-
10.12.26 -- Smarter Decisions Across The Clinical Development Lifecycle
10/12/2026
10/12/26 Cell & Gene Newsletter
-
10.12.26 -- CDMO Selection For Small Biotech: Amit Jain On Avoiding Costly Transfers
10/12/2026
10/12/26 Cell & Gene Newsletter
-
10.10.26 -- Cell & Gene Newsletter - September
10/10/2026
10/10/26 Cell & Gene Newsletter
-
10.09.26 -- How AI Could Clear Logistics Roadblocks Limiting Patient Access To CGT
10/9/2026
10/09/26 Cell & Gene Newsletter
-
10.08.26 -- Streamline Lead Selection & Optimization For Cell Therapy Development
10/8/2026
10/08/26 Cell & Gene Newsletter
-
10.08.26 -- Risk Managing Through The Void Of ATMP Visible Particle Guidance
10/8/2026
10/08/26 Cell & Gene Newsletter
-
10.07.26 -- What's Driving The Next Wave Of Genome Editing?
10/7/2026
10/07/26 Cell & Gene Newsletter
-
10.07.26 -- New USP Guidelines, Standards Address Lentivirus Characterization
10/7/2026
10/07/26 Cell & Gene Newsletter
-
10.06.26 -- Structuring CGT Deals For The Long Term With Troutman Pepper Locke's EA Weeks, J.D., Ph.D.
10/6/2026
10/06/26 Cell & Gene Newsletter